消除耐药性菌根结核病2022年:我们站在哪里
Alessio Lanni1, Angelo Iacobino1, Lanfranco Fattorini1
1Department of Infectious Diseases, Istituto Superiore di Sanità, Via Regina Elena 299, 00161 Rome, Italy.
Microorganisms
|June 28, 2023
概括
新的药物组合有效地杀死休眠结核病 (TB) 细菌,包括持久性和差异检测 (DD) 细胞,为更短的治疗方案铺平道路. 这项研究支持为期4个月的结核病治疗方案.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核病 (TB) 病变有多种 Mycobacterium 结核病菌种群,包括活跃复制 (AR) 和非复制 (NR) 的细菌.
- NR细菌,如持久性和差异检测 (DD) 细胞,是耐药的,并且由于药物透率低和真菌细菌细胞壁,难以根除.
- 目前的结核病疗法对这些休眠阶段和耐药阶段的治疗效果较差.
研究的目的:
- 审查在体外杀死AR和耐药M.结核病 (持久性和DD细胞) 的药物组合.
- 评估这些药物组合在杀菌M.结核病感染的小鼠模型中的有效性.
- 为缩短结核病治疗方案的策略提供最新信息.
主要方法:
- 对针对AR和耐药M.结核病的药物组合体内研究的审查.
- 在结核病的BALB/c和C3HeB/FeJ小鼠模型中评估药物组合疗效.
- 对临床试验数据的分析,以告知治疗方案的变化.
主要成果:
- 几种药物组合在体外显示出对AR和耐药M.结核病的有效性.
- 在受感染的小鼠模型中,使用经过测试的药物组合,成功杀菌了M. tuberculosis.
- 临床试验结果支持药物敏感结核病的4个月治疗方案,正如世卫组织在2022年批准的那样.
结论:
- 针对不同M.结核病细菌阶段的药物组合对于有效的结核病治疗至关重要.
- 新型药物组合在缩短结核病治疗时间方面表现有前途.
- 开发更短,更有效的结核病治疗方案正在推进,为当前的护理标准提供了替代方案.
相关概念视频
Pulmonary Tuberculosis V
214
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214
Pulmonary Tuberculosis II
281
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
281
Pulmonary Tuberculosis I
286
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
286
Pulmonary Tuberculosis IV
175
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
175
Pulmonary Tuberculosis III
381
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
381
Transmission-based Precautions II: Airborne and Protective Environment
1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K


